03-05-2023 : 769 Pharmacists work as Medical Representative, of which 39 work as Senior Medical Representative * 02-06-2020 : 216 non Pharmacists work as Medical Representative, and 54 work as Senior Medical Representative * 05-06-2023 : In Lebanon, 88 generic medicinal products are more expensive than their Originators * 31-12-2019 : A medicinal product refused in Europe is marketed in Lebanon * 05-06-2023 : At least 332 medicinal products are available on the Lebanese market and are not available in the country of origin * 05-06-2023 : The price of the most expensive medicine available in Lebanon is 30434557 LL * 05-06-2023 : At least 1309 medicinal products are more expensive in Lebanon than in the countries of origin * 01-01-2019 : Daktavira, a generic of Daklinza, is registered in Lebanon but has no public price * 31-12-2019 : 352 medicinal products have been declared as non-marketed or withdrawn * 09-11-2021 : 64.72% of lebanese pharmacists are female * 31-12-2019 : 486 medicines were submitted to the Ministry of Health for a marketing authorization, and 514 medicines were registered to date * 15-06-2018 : The Minister of Public Health, has decided to suspend the commercialization of AB Slim (Ab Care Medical Herbs), which contains sibutramine, sildenafil and phenolphthalein * 01-06-2020 : Some Non-Marketed medicines are still imported * 01-06-2020 : Ixempra, a medicinal product withdrawn in Europe is imported to lebanon * 01-06-2020 : A vaccine made in India, removed from WHO list of prequalified vaccines, is submitted for registration in Lebanon * 01-06-2020 : Lebanon has 14 CROs, and is ranked as one of the largest countries in the world in clinical studies. According to the WHO, 817 clinical studies are currently conducted in Lebanon. * 05-01-2021 : * 01-10-2023 : Adakveo is now withdrawn from use in the European Union due to lack of therapeutic efficacy *
Truxima 100mg : | |
Type | Medicine Authorised |
Originator | Mabthera 100mg |
Agent | Droguerie Columbus |
Distributor | Droguerie Columbus |
Laboratory | Celltrion |
Responsible Party | Hikma Pharmaceuticals |
Origin | Jordan |
Manufacturer | Celtrion inc |
Manufacturing Type | G |
Origin | South Korea |
ATC | L01XC02 |
Truxima 100mg :
Truxima 100mg :
Truxima 100mg :
Truxima 100mg :
Truxima 100mg :
Frequency | Percentage |
---|---|
Very Common | ≥ 1/10 |
Common | ≥ 1/100 - < 1/10 |
Uncommon | ≥ 1/1,000 - < 1/100 |
Rare | ≥ 1/10,000 - < 1/1,000 |
Very Rare | < 1/10,000 |
Unknown | Cannot be Estimated |
Effect | Frequency |
---|---|
Abdomen enlarged | Uncommon |
Abdominal pain | Common |
Abdominal pain upper | Common |
Agitation | Common |
Alopecia | Very Common |
ALT increased | Very Common |
Anaemia | Very Common |
Anaphylactic reactions | Rare |
Anaphylactoid reactions | Uncommon |
Anaphylaxis | Uncommon |
Angina pectoris | Uncommon |
Angioedema (Angioneurotic oedema) (Quincke oedema) | Very Common |
Anorexia | Common |
Anxiety | Common |
Aplastic anemia | Uncommon |
Arrhythmia | Common |
Arthralgia (Pain joint) (Joint ache) | Very Common |
Asthenia | Very Common |
Asthma | Uncommon |
Atrial fibrillation | Common |
Back pain | Common |
Bacterial infection | Very Common |
Bradycardia | Uncommon |
Bronchitis | Very Common |
Bronchospasm | Uncommon |
Bullous disorder | Very rare |
Bursitis | Common |
Cardiac failure | Common |
Cephalea | Very Common |
Chest pain | Common |
Chills | Very Common |
Coagulation disorders | Uncommon |
Cold syndrome | Common |
Conjunctivitis | Common |
Constipation | Common |
Cough | Very Common |
Cytomegalovirus infection | Very rare |
Death due to respiratory failure | Very rare |
Depression | Uncommon |
Diarrhoea (Diarrhea) | Very Common |
Dizziness | Common |
Dysguesia (taste perversion) (Taste abnormality) (Taste disturbance) | Uncommon |
Dysphagia | Common |
Dyspnoea (dyspnea) | Very Common |
Epistaxis (Nasal bleeding) | Very Common |
Face oedema | Common |
Facial paralysis | Very rare |
Fatigue | Very Common |
Febrile infection | Common |
Febrile neutropenia (Neutropenic fever) | Very Common |
Flushing | Common |
Fungal infection | Common |
Gastroenteritis | Common |
Gastrointestinal obstruction | Very rare |
Gastrointestinal perforation | Very rare |
Gastrooesophageal reflux disease | Common |
Generalized oedema | Uncommon |
Granulocytopenia | Common |
Haemolytic anemia | Uncommon |
Headache | Very Common |
Hearing loss | Very rare |
Hepatitis | Very rare |
Hepatitis B | Common |
Hepatitis B reactivation | Very rare |
Hepatitis C | Common |
Hepatitis fulminant | Very rare |
Herpes virus infection | Very rare |
Herpes zoster | Common |
Hot flush | Common |
Hypercholesterolaemia | Common |
Hyperglycaemia | Common |
Hypersensitivity reactions | Common |
Hypertension | Very Common |
Hyperuricaemia | Common |
Hypocalcaemia | Common |
Hypoesthesia | Common |
Hypogammaglobulinaemia | Very rare |
Hypotension | Common |
Hypoxia | Uncommon |
IgG levels decreased | Very Common |
Infection | Very Common |
Infection of unknown etiology | Common |
Infusion related reaction | Very Common |
Infusion related reaction with fatal outcome | Very rare |
Infusion site pain | Uncommon |
Insomnia | Very Common |
Interstitial pneumonitis | Not known |
JC virus-associated progressive multifocal leukoencephalopathy | Very rare |
Lacrimal disorder | Common |
Laryngeal oedema | Uncommon |
LDH elevated | Common |
Left ventricular failure | Uncommon |
Leucopenia (Leukopenia) | Very Common |
Lyell Syndrome (Toxic epidermal necrolysis) | Very rare |
Lymphadenopathy | Uncommon |
Malaise | Common |
Migraine | Common |
Mouth ulceration | Common |
Muscle spasms | Very Common |
Myalgia | Common |
Myocardial infarction | Common |
Myocardial ischaemia | Uncommon |
Nausea | Very Common |
Neck pain | Common |
Nervousness | Uncommon |
Neuropathy peripheral | Very rare |
Neutropenia | Very Common |
Night sweats | Common |
Obliterative bronchiolitis (Bronchiolitis obliterans) | Uncommon |
Oedema peripheral | Very Common |
Orthostatic hypotension | Common |
Osteoarthritis | Common |
Otalgia (Earache) (Ear pain) | Common |
Pain | Common |
Pancytopenia | Common |
Paraesthesia (paresthesia) | Common |
Platelet count decreased (Thrombocyte count decreased) | Very Common |
Pneumonia | Common |
Posterior reversible leukoencephalopathy syndrome (PRES) | Very rare |
Progressive multifocal leukoencephalopathy | Very rare |
Pruritus | Very Common |
Pruritus generalized | Uncommon |
Pulmonary oedema | Rare |
Pyrexia | Very Common |
Renal failure acute (Acute renal insufficiency) (Kidney failure acute) (Renal insufficiency acute) | Very rare |
Respiratory failure | Uncommon |
Respiratory tract infection | Common |
Rhinitis | Common |
Sciatica | Common |
Sensory disturbance | Very rare |
Septicemia | Common |
Serum sickness-like reaction | Very rare |
Sinusitis | Common |
Skin rash | Very Common |
Stevens-Johnson syndrome | Very rare |
Stomatitis | Common |
Supraventricular tachycardia | Uncommon |
Sweating | Common |
Tachycardia | Common |
Throat irritation | Common |
Tinea pedis | Common |
Tinnitus | Common |
Tremor | Common |
Tumour pain | Common |
Upper respiratory tract infection | Very Common |
Urinary tract infection | Very Common |
Urticaria | Common |
Vasculitis | Very rare |
Vasodilation | Common |
Ventricular tachycardia | Uncommon |
Viral infection | Very Common |
Vision loss | Very rare |
Vomiting | Common |
Weight decreased (Weight loss) | Common |
Wheezing | Uncommon |
Truxima 100mg :
NB : Products With Same Indication |
Different Units By MoH Code
Truxima 100mg MoH 10673 :
Form | Concentrate for solution for infusion |
Packaging | Bottle (Glass) |
Package Size | 2x10ml |
Strength | 100mg |
Public Price | 12979811.58 L.L. |
Stratum | D |
NSSF | ✘ |
Quarantine | ✘ |
Reg. Number | 195819/1 |
Submission date | 16/12/2019 |
Registration Year | 1/02/2022 |
Pending Year | 09/04/2020 |
Price Comparison
● Country: | Italy | |
● Package Size: | 2 | |
● Public Price: | 661.56 EUR | ( 64,089,286.56 LBP ) |
● Pack size unit used: | 2 | |
● Cost/Unit: | 330,78 EUR | ( 31,969,080.00 LBP ) |
● Exfactory Price: | 400.84 EUR | |
● Pricing Date: | 17/12/2019 | |
● Type: | Medicine Authorised |
● Country: | Iceland | |
● Package Size: | 2x10ml | |
● Public Price: | 93134 ISK | ( 60,071,430.00 LBP ) |
● Pack size unit used: | 2 | |
● Cost/Unit: | 46567 ISK | ( 30,035,715.00 LBP ) |
● Pharmacy Price: | 71110 ISK | ( 45865950 LBP ) |
● Reference: | Icelandic Medicines Agency | |
● Pricing Date: | 01/04/2020 | |
● Type: | Medicine Authorised |
● Country: | Switzerland | |
● Package Size: | 10ml | |
● Public Price: | 505.5 CHF | ( 52,278,810.00 LBP ) |
● Pack size unit used: | 2 | |
● Cost/Unit: | 252,75 CHF | ( 26,061,840.00 LBP ) |
● Exfactory Price: | 426.05 CHF | |
● Pricing Date: | 04/04/2021 | |
● Type: | Medicine Authorised |
● Country: | Jordan | |
● Package Size: | 2 | |
● Public Price: | 400.4 JOD | ( 50,138,488.40 LBP ) |
● Pack size unit used: | 2 | |
● Cost/Unit: | 200,2 JOD | ( 25,044,200.00 LBP ) |
● Reference: | JFDA | |
● Pricing Date: | 25/05/2020 | |
● Type: | Medicine Authorised |
● Country: | The Netherlands | |
● Package Size: | 2 | |
● Public Price: | 515.87 EUR | ( 49,975,422.12 LBP ) |
● Pack size unit used: | 2 | |
● Cost/Unit: | 257,935 EUR | ( 24,897,132.00 LBP ) |
● Pharmacy Price: | 508.87 EUR | ( 49297290.12 LBP ) |
● Reference: | Zorginstituut Nederland | |
● Pricing Date: | 03/03/2020 | |
● Type: | Medicine Authorised |
● Country: | Abu Dhabi | |
● Package Size: | 10ml Vial x 2 | |
● Public Price: | 1844 AED | ( 44,552,884.00 LBP ) |
● Pack size unit used: | 2 | |
● Cost/Unit: | 922 AED | ( 22,276,442.00 LBP ) |
● Pharmacy Price: | 1571.18 AED | ( 37961279.98 LBP ) |
● Pricing Date: | 27/01/2021 | |
● Type: | Medicine Authorised |
● Country: | Cyprus | |
● Package Size: | 2 VIAx100mg | |
● Public Price: | 447.33 EUR | ( 43,335,541.08 LBP ) |
● Pack size unit used: | 2 | |
● Cost/Unit: | 223,665 EUR | ( 21,603,348.00 LBP ) |
● Reference: | Cyprus Minister of Health | |
● Pricing Date: | 24/03/2021 | |
● Type: | Medicine Authorised |
● Country: | Belgium | |
● Package Size: | 2 | |
● Public Price: | 421 EUR | ( 40,784,796.00 LBP ) |
● Pack size unit used: | 2 | |
● Cost/Unit: | 210,5 EUR | ( 20,343,960.00 LBP ) |
● Reference: | cbip | |
● Pricing Date: | 02/12/2020 | |
● Type: | Medicine Authorised |
● Country: | Czech Republic | |
● Package Size: | 2x10ML | |
● Public Price: | 9875.16 CZK | ( 37,713,236.04 LBP ) |
● Pack size unit used: | 2 | |
● Cost/Unit: | 4937,58 CZK | ( 18,854,403.00 LBP ) |
● Reference: | SUKL | |
● Pricing Date: | 28/02/2020 | |
● Type: | Medicine Authorised |
● Country: | UK | |
● Package Size: | 2 vial | |
● Public Price: | 314.33 GBP | ( 35,723,290.17 LBP ) |
● Pack size unit used: | 2 | |
● Cost/Unit: | 157,165 GBP | ( 17,842,893.00 LBP ) |
● Reference: | DMD | |
● Pricing Date: | 08/03/2021 | |
● Type: | Medicine Authorised |
● Country: | Greece | |
● Package Size: | 2x10ml | |
● Public Price: | 298.88 EUR | ( 28,954,298.88 LBP ) |
● Pack size unit used: | 2 | |
● Cost/Unit: | 149,44 EUR | ( 14,434,524.00 LBP ) |
● Exfactory Price: | 248.02 EUR | |
● Pharmacy Price: | 251.75 EUR | ( 24388533 LBP ) |
● Reference: | National Organization for Medicines | |
● Pricing Date: | 25/02/2021 | |
● Type: | Medicine Authorised |
● Country: | France | |
● Package Size: | 2 | |
● Public Price: | 284.4 EUR | ( 27,551,534.40 LBP ) |
● Pack size unit used: | 2 | |
● Cost/Unit: | 142,2 EUR | ( 13,756,392.00 LBP ) |
● Reference: | ansm | |
● Pricing Date: | 15/05/2021 | |
● Type: | Medicine Authorised |
● Country: | Lebanon | |
● Form: | Concentrate for solution for infusion | |
● Package Size: | 2x10ml | |
● Public Price: | 12979811.58 LBP | ( 12,979,811.58 LBP ) |
● Pack size unit used: | 2 | |
● Cost/Unit: | 6489905,79 LBP | ( 6,489,905.00 LBP ) |
● Pricing Date: | 13/06/2024 |
● Country: | Spain |
● Package Size: | 2x10ml |
● Reference: | Agencia Española de Medicamentos y Productos Sanitarios |
● Pricing Date: | 06/05/2021 |
● Type: | Medicine Authorised |
● Country: | Finland |
● Package Size: | 2x100mg |
● Reference: | Kela |
● Pricing Date: | 22/04/2021 |
● Type: | Medicine Non Marketed |
Note
You have to register to view this info
Drop File